Temozolomide combined with radiotherapy in the treatment of recurrent cranial meningioma previously treated with multiple surgical resections and two sessions of radiosurgery: a case report and literature review
- PMID: 22825521
- DOI: 10.1700/1125.12413
Temozolomide combined with radiotherapy in the treatment of recurrent cranial meningioma previously treated with multiple surgical resections and two sessions of radiosurgery: a case report and literature review
Abstract
Meningioma is a common primary brain tumor in adults. The treatment approach depends on its grade, size and symptoms. The case reported here was a repeatedly recurring transitional meningioma, previously treated with several surgical procedures and two sessions of cranial radiosurgery. At the time of last relapse, temozolomide was administered alone and combined with external beam radiation therapy. At the last follow-up after 38 months, the disease was stable. In conclusion, in this case of plurirecurrent meningioma, treatment with temozolomide alone and in combination with radiotherapy was feasible and associated with limited morbidity, providing clinical benefit and long local disease control. We discuss the case comparing our approach with other experiences reported in the literature.
Similar articles
-
Boron neutron capture therapy for recurrent malignant meningioma. Case report.J Neurosurg. 2006 Dec;105(6):898-903. doi: 10.3171/jns.2006.105.6.898. J Neurosurg. 2006. PMID: 17405262
-
Temozolomide for recurrent meningiomas: a case-report with unexpected clinical and radiological response.J Neurooncol. 2016 Mar;127(1):201-3. doi: 10.1007/s11060-015-2016-6. Epub 2015 Nov 27. J Neurooncol. 2016. PMID: 26614515 No abstract available.
-
Atypical teratoid/rhabdoid tumors in adult patients: case report and review of the literature.J Neurooncol. 2001 Mar;52(1):49-56. doi: 10.1023/a:1010683416555. J Neurooncol. 2001. PMID: 11451202 Review.
-
Contemporary management of meningiomas: radiation therapy as an adjuvant and radiosurgery as an alternative to surgical removal?J Neurosurg. 1994 Feb;80(2):187-90. doi: 10.3171/jns.1994.80.2.0187. J Neurosurg. 1994. PMID: 8283254 No abstract available.
-
Role of radiation therapy in treating intracranial meningiomas.Neurosurg Focus. 2007;23(4):E4. doi: 10.3171/FOC-07/10/E4. Neurosurg Focus. 2007. PMID: 17961041 Review.
Cited by
-
Evaluation of a procaspase-3 activator with hydroxyurea or temozolomide against high-grade meningioma in cell culture and canine cancer patients.Neuro Oncol. 2021 Oct 1;23(10):1723-1735. doi: 10.1093/neuonc/noab161. Neuro Oncol. 2021. PMID: 34216463 Free PMC article.
-
Concomitant Temozolomide plus radiotherapy for high-grade and recurrent meningioma: a retrospective chart review.BMC Cancer. 2022 Apr 7;22(1):367. doi: 10.1186/s12885-022-09340-7. BMC Cancer. 2022. PMID: 35392834 Free PMC article.
-
Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo.Cancers (Basel). 2021 Nov 24;13(23):5898. doi: 10.3390/cancers13235898. Cancers (Basel). 2021. PMID: 34885009 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical